Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ronald M. Fairman, MD, J. Michael Tuchek, DO, W

Similar presentations


Presentation on theme: "Ronald M. Fairman, MD, J. Michael Tuchek, DO, W"— Presentation transcript:

1 Pivotal results for the Medtronic Valiant Thoracic Stent Graft System in the VALOR II trial 
Ronald M. Fairman, MD, J. Michael Tuchek, DO, W. Anthony Lee, MD, Karthikeshwar Kasirajan, MD, Rodney White, MD, Manish Mehta, MD, Sean Lyden, MD, Dipankar Mukherjee, MD, Joseph Bavaria, MD  Journal of Vascular Surgery  Volume 56, Issue 5, Pages e1 (November 2012) DOI: /j.jvs Copyright © 2012 Society for Vascular Surgery Terms and Conditions

2 Fig 1 The Valiant Thoracic Stent Graft.
Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Patient accountability and determination of the population evaluable for end point analysis in the VALOR II (Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair) trial of the Valiant Thoracic Stent Graft System. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Kaplan-Meier plot of 12-month freedom from all-cause mortality for VALOR II (Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair) patients implanted with the Valiant Thoracic Stent Graft vs VALOR (Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms) test-group patients implanted with the Talent Thoracic Stent Graft. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

5 Fig 4 Kaplan-Meier plot of 12-month freedom from aneurysm-related mortality for VALOR II (Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair) patients implanted with the Valiant Thoracic Stent Graft vs VALOR (Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms) test-group patients implanted with the Talent Thoracic Stent Graft. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions


Download ppt "Ronald M. Fairman, MD, J. Michael Tuchek, DO, W"

Similar presentations


Ads by Google